BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7488122)

  • 1. Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation.
    Strasberg Rieber M; Rieber M
    Biochem Biophys Res Commun; 1995 Nov; 216(1):422-7. PubMed ID: 7488122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation.
    Rieber M; Rieber MS
    Cell Growth Differ; 1994 Dec; 5(12):1339-46. PubMed ID: 7696182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2.
    Gorospe M; Liu Y; Xu Q; Chrest FJ; Holbrook NJ
    Mol Cell Biol; 1996 Mar; 16(3):762-70. PubMed ID: 8622677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
    Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
    Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
    Said TK; Luo L; Medina D
    Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK4/cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and G0 arrest of human fibroblasts.
    Gadbois DM; Peterson S; Bradbury EM; Lehnert BE
    Exp Cell Res; 1995 Sep; 220(1):220-5. PubMed ID: 7664838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
    Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
    Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.
    Masciullo V; Scambia G; Marone M; Giannitelli C; Ferrandina G; Bellacosa A; Benedetti Panici P; Mancuso S
    Int J Cancer; 1997 Aug; 74(4):390-5. PubMed ID: 9291427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
    L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
    Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity.
    Lilischkis R; Sarcevic B; Kennedy C; Warlters A; Sutherland RL
    Int J Cancer; 1996 Apr; 66(2):249-54. PubMed ID: 8603820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo.
    Fu YM; Yu ZX; Ferrans VJ; Meadows GG
    Nutr Cancer; 1997; 29(2):104-13. PubMed ID: 9427972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations associated with familial melanoma impair p16INK4 function.
    Ranade K; Hussussian CJ; Sikorski RS; Varmus HE; Goldstein AM; Tucker MA; Serrano M; Hannon GJ; Beach D; Dracopoli NC
    Nat Genet; 1995 May; 10(1):114-6. PubMed ID: 7647780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E, a redundant cyclin in breast cancer.
    Gray-Bablin J; Zalvide J; Fox MP; Knickerbocker CJ; DeCaprio JA; Keyomarsi K
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15215-20. PubMed ID: 8986790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.